Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
TruScreen Group Ltd. ( (AU:TRU) ) has provided an update.
TruScreen Group Ltd. has announced a new application for the quotation of securities, with a total of 80,670,455 ordinary fully paid foreign exempt securities to be quoted on the ASX. This move is expected to enhance the company’s financial flexibility and market presence, potentially impacting its operations and positioning within the medical technology industry.
More about TruScreen Group Ltd.
TruScreen Group Ltd. operates in the medical technology industry, focusing on developing and providing advanced cervical cancer screening solutions. The company is known for its innovative TruScreen device, which offers a real-time, non-invasive method for detecting cervical cancer, aiming to improve early diagnosis and treatment outcomes.
Average Trading Volume: 209,479
Technical Sentiment Signal: Sell
Current Market Cap: A$11.32M
For a thorough assessment of TRU stock, go to TipRanks’ Stock Analysis page.